glp-1 and chronic kidney disease Frontiers Design and discovery of a
Description
H.MillerH
persistent symptoms beyond 48 weeks warrant GP review to exclude other causes and optimise treatment
17 35 Therefore, careful clinical monitoring is warranted, especially during the early phases of treatment
Expect a lot of work on these cases in the coming months as the MDL gets underway
Im their poster boy now
Further stratification by obesity class, duration of GLP-1 use, and interval between discontinuation and conception would also strengthen causal interpretation
